Chirag R Parikh MD, PhD, FACP
Associate Professor of Medicine (Nephrology); Director, Program of Applied Translational Research

Departments & Organizations
Internal Medicine: Nephrology: Program for Applied Translational Research (PATR)Biography
My career path has followed the NIH’s call to physician scientists at the turn of this millennium--to pursue translational research and to advance important findings from "bench to bedside." My research rigorously evaluates the novel biomarkers of kidney injury, investigates the mechanisms by which biomarker patterns evolve in various settings of acute kidney injury, and develops innovative strategies to validate them for clinical use. I created the Translational Research Investigating Biomarker End-points (TRIBE) consortium for conducting multi-center studies on biomarkers of AKI, for their validation and subsequent FDA approval (www.yale.edu\tribeaki). The TRIBE Consortium has been very successful: we are conducting NIH sponsored multi-center studies testing biomarkers in the setting of cardiac surgery, kidney transplantation, aging, HIV and hepatorenal syndrome. My research is leading a paradigm change in the field of nephrology with the potential to revolutionize clinical management of kidney diseases.Education
- M.D., Seth G.S. Medical College , 1996
- Ph.D., University of Colorado at Denver , 2000
Selected Publication
- Belcher JM, Edelstein CL, Parikh CR. Clinical applications of biomarkers for acute kidney injury. Am J Kidney Dis. 2011 Jun;57(6):930-40. Epub 2011 Mar 15. PubMed PMID: 21411200.
Articles
Sept/Oct 2011
Protecting the kidneys after heart surgery
Following cardiac surgery, many patients experience acute kidney injury (AKI), a complication that increases the risk...


